Olympus Corporation (Olympus), a global medtech company committed to making people’s lives healthier, safer and more fulfilling, announced that it…
Browsing: HealthCare
Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication by GlobalData and Novotech found almost…
Verseon is delighted to announce that the European Journal of Medicinal Chemistry has published a paper (www.sciencedirect.com/science/article/abs/pii/S0223523422007577) describing the company’s groundbreaking…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital…
Global Offering of 54,633,000 Shares at HK$8.80 Per Offer Share OrbusNeich Medical Group Holdings Limited (OrbusNeich or the Group), a…
A biocompatible polymer could help deliver vaccines and drugs with reduced risk of the rare dangerous adverse reaction called anaphylaxis.…
Recently, Zhongke Guosheng (Hangzhou) Technology Co., Ltd (hereinafter referred to as GS Biotech) officially announced the completion of its nearly…
Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research…
Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & Sullivan Company of the Year Award…
Participating in the Ministry of Internal Affairs and Communications of Japan project to conduct a survey study for international expansion…
As part of Olympus’ dedication to continuing its history of innovation, Olympus is proud to announce the inaugural Olympus Asia Pacific…
Prenetics Global Limited (NASDAQ: PRE) (Prenetics or the Company), a global leader in genomic and diagnostic testing, today announced that…
Steps Up Efforts in Three Business Segments Achieves Leapfrog Development Tianda Pharmaceuticals Limited (Tianda Pharma or the Group; HKG: 0455)…
Net Profit Increases 116% to HK$21.6 Million Declares Interim Dividend of HK0.5 Cent Per Share Resilient Performance as Growth Momentum…
Profit Attributable to Shareholders Increases by Over 70% Declares Interim Dividend of HK2.8 Cents Per Share Solid Growth Momentum Bolstered…
Group seeks investment opportunities to expand reach of products and services Malaysian Genomics Resource Centre Berhad, a leading genomics and…
Continue to Bolster Resilience with Diversified Healthcare Business Strategy Further Consolidating the Healthcare Services Market EC Healthcare (the Company, which…
Maintained decent profitability amid consumption slowdown and Covid-19 shadow Perfect Medical Health Management Limited (the Company , HKG: 1830), one…
The Food and Drug Supervisory Agency (BPOM) has issued emergency use authorization (EUA) for InaVac, a COVID-19 vaccine developed by…
China Resources Pharmaceutical Group Limited (CR Pharmaceutical or the Group) (HKG: 3320) has announced that the Group will once again…